Peripheral blood mononuclear cells (PBMCs) from AD patients also showed greater expression of NLRP3, ASC, caspase-1, caspase-5, IL-1β, and IL-18 (Saresella et al., 2016). This evidence concerns the gene NLRP3 and Alzheimer disease.